CARE Ratings Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹112Cr
- +19.1% YoY
- −14.5% QoQ
- Net profit
- ₹33Cr
- +26.9% YoY
- −37.7% QoQ
- Margin
- 31%
- +1 pp YoY
- −15 pp QoQ
Guidance rank: #20 of 27 in Capital Markets
See the sector's top 10 — free with your mobile number.
CARE Ratings Ltd Q1 FY27 key numbers
- Revenue
- Standalone Operating Income: Rs. 88.15 Cr, up 16.5% YoY.
As stated in CARE Ratings Ltd's Q1 FY27 investor presentation · published 25 Sept 2026. Reported figures, not investment advice.
Based on CARE Ratings Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Consolidated Operating Income for Q1 FY27: Rs. 111.68 Cr, up 18.9% YoY (Page 2, 13). Standalone Q1 FY27:.
From CARE Ratings Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Consolidated Operating Income for Q1 FY27: Rs. 111.68 Cr, up 18.9% YoY (Page 2, 13)
- Standalone Operating Income: Rs. 88.15 Cr, up 16.5% YoY (Page 2, 13)
- Consolidated Ratings Business Revenue: Rs. 98.71 Cr, up 19.1% YoY (Page 2, 13)
- Consolidated Non-Ratings Business Revenue: Rs. 12.97 Cr, up 17.9% YoY (Page 2, 13)
- EBITDA consolidated: Rs. 34.63 Cr, up 24.2% YoY; standalone Rs. 32.09 Cr, up 18.2% YoY (Page 2, 13)
- PAT consolidated: Rs. 32.99 Cr, up 24.6% YoY; standalone Rs. 33.88 Cr, up 16.3% YoY (Page 2, 13)
2 more points from CARE Ratings Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
Standalone Q1 FY27:
Locked: what CARE Ratings Ltd said on margins
Also locked on this page: capex, fundraising, order book
Free account, 30 seconds. No card needed.
Capital Expenditure Plans
See what CARE Ratings Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Capital Markets
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
The focus is on operational financial performance, ratings, advisory services, and outreach activities…
Locked: what CARE Ratings Ltd said on fundraising
Also locked on this page: margins, capex, order book
Free account, 30 seconds. No card needed.
Order Book & Pipeline
See what CARE Ratings Ltd said on order book & pipeline — free account, 30 seconds.
CARE Ratings Ltd — Quarterly revenue & net profit
CARE Ratings Ltd Q1 FY27 results — key figures
| ₹ Cr | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 112 | 94 | +19.1% | 131 | -14.5% |
| Operating profit (EBITDA) | 35 | 28 | +25% | 61 | -42.6% |
| Operating margin | 31% | 30% | +1 pp | 46% | -15 pp |
| Profit before tax | 45 | 37 | +21.6% | 72 | -37.5% |
| Net profit (PAT) | 33 | 26 | +26.9% | 53 | -37.7% |
| EPS (₹) | 10.73 | 8.61 | +24.6% | 17.58 | -39% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹164 Cr, net profit ₹72 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What CARE Ratings's management said in earlier quarters
Others in Capital Markets this season
- Pune e-Stock Broking (Q1 FY27)
For H2 FY26, Revenue from Operations was ₹27.5 Crore, up 20.4% YoY from ₹22.8 Crore in H2 FY25. Key investor presentation takeaways from Pune e-Stock Broking Lt
- Almondz Global (Q1 FY27)
INR 130 Crores for FY26 (Page 10). Key investor presentation takeaways from Almondz Global's Q1 FY27 investor presentation — and how it ranks against sector pee
- Indo Thai Securities (Q1 FY27)
Q4 FY26 Total Revenue: ₹38.41 Cr, up 548% YoY from ₹5.93 Cr in Q4 FY25 (Page 15). Key investor presentation takeaways from Indo Thai Securities's Q1 FY27 invest
- ICRA (Q1 FY27)
Revenue for Q1 FY2027: INR 163.4 crore, up from INR 124.5 crore in Q1 FY2026 (31.2% YoY growth). Key concall takeaways from ICRA Ltd's Q1 FY27 earnings call…
Potential multibaggers · Q2 FY27
Potential multibaggers in Capital Markets
on management's own guidance
- Motilal Oswal Financial ServicesGood growth2
- BSEGood growth1
- Anand Rathi WealthGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
CARE Ratings Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were CARE Ratings Ltd Q1 FY27 results?
Consolidated Operating Income for Q1 FY27: Rs. 111.68 Cr, up 18.9% YoY (Page 2, 13). Standalone Q1 FY27:.
What is CARE Ratings Ltd share price analysis?
CARE Ratings Ltd currently shows a neutral. The stock trades at a P/E of 28.3 with a market cap of ₹5,026 Cr. Investors should review the full earnings analysis for detailed insights.
Keep CARE Ratings Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.